Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention

Cardiology Journal

Volumn 15, Issue 5, 2008, Pages 422-430

  Gasior, Mariusz ^a   Pres, Damian ^a   Stasik Pres, Gabriela ^a   Lech, Piotr ^a   Gierlotka, Marek ^a   Hawranek, Michał ^a   Wilczek, Krzysztof ^a   Szyguła Jurkiewicz, Bozena ^a   Lekston, Andrzej ^a   Kalarus, Zbigniew ^a   Strojek, Krzysztof ^a   Gumprecht, Janusz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetes mellitus; Hyperglycemia; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; INSULIN; MORPHINE; ORAL ANTIDIABETIC AGENT; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; DIET THERAPY; DRUG TREATMENT FAILURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 54849417620     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gustafsson I, Hildebrandt P, Seibaek M et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J, 2000; 21: 1937-1943.
2. Aguilar D, Solomon SD, Kober L et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation, 2004; 110: 1572-1578.
3. Gasior M, Wasilewski J, Gierlotka M et al. Myocardial infarction in patients with diabetes. Results of primary coronary angioplasty. Kardiol Pol, 2003; 58: 438-448.
4. Polonski L, Gasior M, Gierlotka M et al. Epidemiology, treatment and prognosis in the acute coronary syndromes in Silesian region. The outcomes of pilot Polish Registry of Acute Coronary Syndromes PL=ACS. Kardiol Pol, 2005; suppl. 1: i22-i27.
5. Kannel WB, McBee DL. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation, 1979; 59: 8-13.
6. Harjai KJ, Stone GW, Boura J et al. Comparison of outcomes of diabetic and non-diabetic patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol, 2003; 91: 1041-1045.
7. Silva JA, Ramee SR, White CJ et al. Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome. Am Heart J, 1999; 138: 446-455.
8. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet, 2000; 355: 773-778.
9. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol, 2005; 96: 183-186.
10. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all--cause mortality risk in diabetic patients with acute coronary events. Eur Heart J, 2005; 26: 1255-1261.
11. Foo K, Cooper J, Deaner A et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart, 2003; 89: 512-516.
12. Kosiborod M, Rathore SS, Inzucchi SE et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation, 2005; 111: 3078-3086.
13. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Circulation, 1999; 99: 2626-2632.
14. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol, 2002; 40: 1748-1754.
15. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med, 2005; 22: 1321-1325.
16. Stranders I, Diamant M, van Gelder RE et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med, 2004; 164: 982-988.
17. Timmer JR, van der Horst IC, Ottervanger JP et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J, 2004; 148: 399-404.
18. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care, 1999; 22: 1827-1831.
19. Kosuge M, Kimura K, Kojima S et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J, 2005; 69: 375-379.
20. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med, 1985; 312: 932-936.
21. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed), 1986; 293: 917-922.
22. Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J, 2001; 22: 1102-1110.
23. Conaway DG, O'Keefe JH, Reid KJ, Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol, 2005; 96: 363-365.
24. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 2003; 26 (suppl. 1): S5-S20.
25. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care, 2003; 26 (suppl. 1): S21-S24.
26. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Diagnosis and classification of diabetes mellitus-provisional report of a WHO consultation. Diabet Med, 1998; 15: 539-553.
27. Ishihara M, Kojima S, Sakamoto T et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J, 2005; 150: 814-820.
28. Ishihara M, Inoue I, Kawagoe T et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J, 2003; 146: 674-678.
29. Iwakura K, Ito H, Ikushima M et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol, 2003; 41: 1-7.